… with a poorer prognosis and enhanced resistance to cisplatin and tyrosine kinase inhibitors.
… -5 in gastric cancer, the advances made in the prediction of the failure of chemotherapy, and …

… The mechanisms of chemotherapy resistance in gastric cancer are complex and multifactorial.
A variety of factors have been demonstrated to be involved in chemoresistance, including …

… and converts cell phenotype toward malignant, contributing to chemoresistance and poor
prognosis of gastric cancer. The experimental data on the resistance of GC to cisplatin and 5-…

… In this study, we found that constitutive overexpression of the MDR1 gene in drug-resistant
human gastric cancer SGC7901/VCR cells is dependent on phosphorylation of p38 and the …

… Clinically recommended chemotherapy regimens for gastric cancer include FLOT and
FOLFOX regimens, which can effectively prolong the overall survival of advanced GC. Citation34 …

… Chemotherapy is one of the major treatment options for advanced gastric cancer. The
efficacy of chemotherapy for gastric cancer is poor due to insensitivity and the development of …

… gastric CSC phenotypes, including chemotherapy resistance. We grew three different gastric
cancer cell … cells were highly resistant to 5-fluorouracil or cisplatin chemotherapy, and this …

… resistance of human gastric cancer. The absence of P-gp and MRP1 expression in some
gastric cancer … 20 years on gastric cancer chemotherapy and drug resistance appear to have an …

… might act as an oncogene in gastric cancer. However, little is … and chemotherapy resistance
in gastric cancer cells. In this … and chemotherapy resistance to adriamycin in gastric cancer …

… However, the drug-resistance to the chemotherapy restricts its effect and … resistance in
gastric cancer. And we also want to find new approaches to counteract chemotherapy resistance …